🌱 Canada right now: Pacific 9:53 am Mountain 10:53 am SK* 10:53 am Central 11:53 am Eastern 12:53 pm Atlantic 1:53 pm NL 2:23 pm *SK no DST
Sleep Supplements

5-HTP for sleep Canada: the serotonin pathway, what the evidence shows, and the drug interaction you must know about

5-HTP for sleep in Canada works through one of the most direct serotonin-to-melatonin pathways of any supplement — but it is also one of the few sleep supplements with a genuinely serious drug interaction risk. This guide covers the mechanism, the honest clinical evidence, dose and timing, why the carbidopa problem matters, the SSRI/MAOI serotonin syndrome warning in plain terms, and how to buy a Health Canada NPN-verified product.

Updated: April 2026 13 min read Evidence-based

How long does 5-HTP take to work for sleep?

5-HTP for sleep typically takes 1–2 weeks of nightly use before consistent improvement is noticed. This is faster than valerian (2–4 weeks) but slower than melatonin (30 minutes) or L-theanine (45 minutes). The delay reflects the mechanism: 5-HTP increases serotonin synthesis, and the brain uses elevated serotonin to produce more nocturnal melatonin — an indirect, accumulative process rather than a direct sedative effect.

Some people notice mild drowsiness on the first night at 100 mg, which is a sign of adequate serotonin conversion. Others notice nothing for 5–7 days. Do not increase the dose prematurely — the serotonin pathway needs consistent substrate availability before sleep architecture improvements manifest. Take 100 mg every night for 2 weeks before evaluating whether it is working and before increasing to 200 mg.

Quick reference: 100 mg of 5-HTP (Griffonia simplicifolia, NPN-verified), taken 30–45 minutes before bed, every night for at least 2 weeks. Do not combine with SSRIs, SNRIs, MAOIs, or tramadol.

How 5-HTP works: the serotonin pathway

5-hydroxytryptophan (5-HTP) is the direct metabolic precursor to serotonin. It is extracted primarily from Griffonia simplicifolia seeds and is one step closer to serotonin than L-tryptophan (the dietary amino acid found in turkey and dairy). Understanding the pathway explains both why it works and why the timing of supplementation matters.

Step 1
5-HTP → Serotonin
5-HTP crosses the blood-brain barrier and is decarboxylated by aromatic L-amino acid decarboxylase (AADC) into serotonin (5-hydroxytryptamine, 5-HT). This conversion happens both in the brain and in peripheral tissues (gut, platelets). The brain conversion is what matters for sleep — the peripheral conversion is a limitation we will address in the dose section.
→
Step 2
Serotonin → N-acetylserotonin
In the pineal gland at night, serotonin is converted to N-acetylserotonin by the enzyme arylalkylamine N-acetyltransferase (AANAT) — a step that is rate-limited by darkness. This is why light exposure suppresses melatonin production: it inhibits AANAT activity. Higher serotonin availability in the evening (from 5-HTP) means more substrate for this conversion, provided you are in dim light.
→
Step 3
N-acetylserotonin → Melatonin
Hydroxyindole-O-methyltransferase (HIOMT) converts N-acetylserotonin to melatonin (N-acetyl-5-methoxytryptamine). This is the final step. The melatonin produced is endogenous — released by the pineal gland in a physiologically appropriate pulse, unlike exogenous melatonin supplements which provide a single bolus dose. Endogenous melatonin production via 5-HTP may produce a more sustained melatonin curve than taking melatonin directly.

Why timing is critical

The serotonin-to-melatonin conversion (Step 2) only occurs in darkness. AANAT enzyme activity is suppressed by light via the retinohypothalamic tract. This has a direct practical implication: if you take 5-HTP and then spend another 2 hours on a bright screen, the serotonin you have produced is less likely to be converted to melatonin — it will instead be metabolised through other serotonin pathways (monoamine oxidase breakdown, peripheral uptake). Take 5-HTP 30–45 minutes before you intend to be in dim light and moving toward sleep. The combination of 5-HTP plus darkness is what generates the melatonin benefit.

5-HTP is not melatonin: 5-HTP increases serotonin, which can be converted to melatonin, but also serves many other functions (mood, appetite, gut motility, platelet aggregation). You cannot control precisely how much of the serotonin goes to melatonin. This is why direct melatonin (0.5 mg) is more predictable for circadian timing and jet lag, while 5-HTP is better suited for people whose sleep problem is linked to low serotonin tone (mood, anxiety, chronic stress).

Dose, timing, and the carbidopa problem

5-HTP dosing for sleep is more nuanced than most supplement guides suggest. The optimal dose depends on tolerability, the peripheral conversion problem, and whether you are using it acutely or cumulatively.

Dose Expected effect GI tolerance Notes
50 mg Sub-threshold for most; mild serotonin increase Excellent Useful starting dose for highly sensitive individuals or those titrating carefully. Not likely sufficient for meaningful sleep benefit at this level.
100 mg Reliable serotonin increase; mild drowsiness; 1–2 week sleep benefit onset Good — take with light snack to reduce nausea The standard evidence-based starting dose for sleep. Most positive trials in the 100–200 mg range. Take 30–45 min before bed, in dim light.
200 mg Stronger effect; notable drowsiness in most people; improved sleep quality over weeks Moderate — nausea more likely on empty stomach Increase to this dose only after 2 weeks at 100 mg with no side effects. Not recommended as a starting dose. Always take with a small meal or snack.
300 mg+ Diminishing sleep returns; significant nausea and GI distress risk Poor — most people experience nausea Doses above 300 mg/day should only be used under medical supervision. Higher doses are used in some depression research but are not appropriate for sleep supplementation. Serotonin-related adverse effects increase substantially above 300 mg.

The peripheral conversion problem

This is the detail most 5-HTP guides omit. When you take 5-HTP orally, a significant portion is converted to serotonin in peripheral tissues — the gut wall, platelets, and liver — before it reaches the brain. Peripheral serotonin cannot cross the blood-brain barrier. This means a substantial fraction of each dose never contributes to brain serotonin, limiting the sleep and mood effect of any given dose.

The workaround used in some clinical trials is to co-administer carbidopa — a peripheral decarboxylase inhibitor that blocks peripheral 5-HTP conversion, preserving more 5-HTP for brain delivery. Carbidopa is a prescription drug in Canada (used in Parkinson's disease treatment). It cannot be purchased over the counter. The practical implication: the doses effective in carbidopa co-administration trials are not directly comparable to OTC supplementation doses. At 100–200 mg OTC 5-HTP, expect some peripheral conversion loss. This is why some clinicians suggest slightly higher doses than the early trials used.

Timing protocol

Take 5-HTP 30–45 minutes before entering a dim-light environment and moving toward sleep. The enzyme that converts serotonin to melatonin (AANAT) is inhibited by light — so taking 5-HTP and then continuing to use bright screens or overhead lighting wastes a significant portion of the serotonin on non-melatonin pathways. Dim the lights when you take 5-HTP. Always take with food or a light snack to reduce nausea from peripheral serotonin in the GI tract.

Titration protocol: Week 1–2: 100 mg with a small snack 30–45 min before bed, lights dimmed. Week 3–4: if no GI issues and benefit is partial, increase to 150–200 mg. Stop at 200 mg for sleep use. If you develop nausea, reduce back to 100 mg and take with more food.

5-HTP vs. melatonin vs. L-tryptophan

These three are frequently confused because they share the same biochemical pathway. They address different parts of the problem and have meaningfully different risk profiles.

Factor 5-HTP Melatonin L-Tryptophan
Position in pathway Tryptophan → 5-HTP → Serotonin → Melatonin End product — directly replaces endogenous melatonin Dietary amino acid — two steps from serotonin
Primary effect Increases serotonin → indirect melatonin boost + mood/anxiety benefit Circadian clock signal; sleep onset timing Increases serotonin (less efficiently than 5-HTP); mood and sleep quality
Onset of action 1–2 weeks (gradual serotonin build); mild acute drowsiness possible 30–60 minutes; acute on first dose 2–4 weeks; slowest of the three
BBB penetration High — 5-HTP crosses BBB efficiently without competing transporters High — direct passage Moderate — competes with other large neutral amino acids at blood-brain barrier; food blunts uptake
Best use case Sleep difficulty linked to anxiety, low mood, or stress; REM improvement Circadian misalignment — jet lag, shift work, delayed sleep phase Mood support + mild sleep improvement; good for people who want whole-food-proximate supplementation
Drug interaction risk High — serotonin syndrome with SSRIs, MAOIs, tramadol Low — mild CYP1A2 interaction only Moderate — same serotonin syndrome risk as 5-HTP; less potent but same mechanism
Typical Canadian dose 100–200 mg at bedtime 0.5–1 mg at bedtime 500–2000 mg at bedtime
Nausea risk Common at doses ≥200 mg; especially on empty stomach Rare at ≤1 mg; more common at 5–10 mg Less than 5-HTP at typical doses
Canadian availability NHP, NPN required; Shoppers, Well.ca, Amazon.ca NHP, NPN required; max OTC 10 mg; ubiquitous NHP, NPN required; less common than 5-HTP
Decision guide: If your sleep problem is primarily about timing (can't fall asleep at your target time, night owl schedule, jet lag), melatonin is the right choice. If your sleep difficulty is tied to low mood, anxiety, or chronic stress, 5-HTP addresses the upstream serotonin deficit and may improve both sleep and mood. If you want the gentlest entry into this pathway with lower GI side effect risk, L-tryptophan is slower but better tolerated. Do not combine any two of these in a way that stacks serotonergic load.

What the research actually shows

The 5-HTP sleep evidence base is smaller and more heterogeneous than melatonin or even valerian. Most positive trials involve sleep as a secondary outcome — the primary target was depression, anxiety, or fibromyalgia. Here are the key studies:

Trial / Author Design Dose & Duration Key finding Limitation
Soulairac & Lambinet (1977)
Thérapie		 RCT, n=30 insomniacs 100 mg 5-HTP at bedtime; 4 weeks Significant reduction in sleep onset latency and night awakenings. One of the first controlled trials showing 5-HTP sleep benefit. Small sample; 1977 methodology; no polysomnography; not independently replicated at this dose.
Wyatt et al. (1971)
Electroencephalogr Clin Neurophysiol		 RCT crossover, PSG, n=7 600 mg L-5-HTP; single dose Significant increase in REM sleep duration on PSG. First objective evidence that 5-HTP affects sleep architecture — specifically REM, not just onset latency. Very high dose (600 mg; far above typical supplementation range); tiny sample; acute single-dose design.
Guilleminault et al. (1973)
Sleep		 Observational, n=15, PSG 100–600 mg nightly; variable duration 5-HTP increased REM sleep and reduced sleep onset time in patients with various sleep disorders. Dose-dependent REM increase observed on PSG. No placebo control; heterogeneous population; high dose range.
Birdsall (1998)
Altern Med Rev (review)		 Narrative review Various (50–600 mg) Synthesised evidence for 5-HTP in sleep, depression, and anxiety. Concluded 5-HTP is well-absorbed, crosses BBB efficiently, and has evidence for improving sleep quality, particularly REM, in insomniacs. Narrative review, not meta-analysis; includes weak studies; some author conflicts of interest.
Caruso et al. (1990)
J Int Med Res		 RCT, n=50, fibromyalgia + sleep disorder 100 mg 5-HTP three times daily; 90 days Significant improvements in sleep quality, pain, morning stiffness, and fatigue scores vs. placebo. Sleep improvement was a primary secondary outcome. Fibromyalgia population — may not generalise to primary insomnia. TID dosing (not bedtime-only). 90-day duration not replicable without medical supervision.
Honest assessment: The 5-HTP sleep evidence base is real but limited. The strongest signal is for REM sleep enhancement (Wyatt, Guilleminault) and sleep onset reduction in people with underlying low serotonin tone (anxiety, depression, fibromyalgia). There are no large, well-powered RCTs using modern sleep assessment methods in healthy insomniacs at supplemental doses (100–200 mg). Most people using 5-HTP for sleep are extrapolating from small trials, mechanistic rationale, and clinical reports. This is not unusual for supplements, but it should inform expectations: 5-HTP is most likely to benefit people whose sleep difficulty is mood- or anxiety-adjacent. For primary insomnia in otherwise healthy people, the evidence is weaker.

Drug interactions and serotonin syndrome

This is the most important section of this guide. 5-HTP has a more clinically significant drug interaction profile than almost any other commonly sold sleep supplement in Canada. The central risk is serotonin syndrome — a potentially serious, sometimes life-threatening condition caused by excess serotonergic activity in the CNS and periphery.

Drug / Substance Risk Mechanism Action required
SSRIs
(fluoxetine / Prozac, sertraline / Zoloft, escitalopram / Cipralex, paroxetine, citalopram, fluvoxamine)		 CRITICAL — Do not combine SSRIs block serotonin reuptake. 5-HTP increases serotonin synthesis. Combined, these two mechanisms produce excessive synaptic serotonin — the direct cause of serotonin syndrome. Do not take 5-HTP if you are on any SSRI. No exceptions without explicit physician approval and monitoring.
SNRIs
(venlafaxine / Effexor, duloxetine / Cymbalta, desvenlafaxine)		 CRITICAL — Do not combine Same mechanism as SSRIs. SNRIs inhibit reuptake of both serotonin and norepinephrine — the serotonin component creates the same serotonin syndrome risk as SSRIs. Do not combine. Consult your prescribing physician.
MAOIs
(phenelzine, tranylcypromine, moclobemide / Manerix — the most commonly prescribed MAOI in Canada)		 CRITICAL — Do not combine MAOIs inhibit monoamine oxidase, which breaks down serotonin. Combined with 5-HTP (which increases serotonin production), serotonin accumulates to potentially dangerous levels. Moclobemide (Manerix) is a reversible MAOI widely prescribed in Canada — do not take 5-HTP with it. Do not combine under any circumstances.
Tramadol
(Ultram, Tramacet)		 High — Do not combine Tramadol has serotonin reuptake inhibition properties in addition to its opioid effects. Cases of serotonin syndrome with tramadol + serotonergic supplements are documented. Commonly prescribed in Canada for pain. Do not combine. Discuss with prescribing physician.
Triptans
(sumatriptan / Imitrex, rizatriptan / Maxalt, naratriptan / Amerge)		 High — Avoid combination Triptans are serotonin (5-HT1B/1D) receptor agonists. Adding 5-HTP increases available serotonin for these receptors. Serotonin syndrome cases with triptans and 5-HTP have been reported. Triptans are widely used in Canada for migraines. Do not combine on the same day. Discuss with your neurologist if you use triptans regularly.
St. John's Wort
(Hypericum perforatum)		 High — Do not combine St. John's Wort inhibits serotonin reuptake (among other mechanisms). Widely sold in Canada as an NHP for mood. The combination with 5-HTP has the same theoretical serotonin syndrome risk as SSRIs. Do not combine. Both are available OTC in Canada — many people are unaware of this interaction.
Dextromethorphan (DXM)
(in many Canadian cold medicines — Robitussin DM, Benylin, Buckley's)		 Moderate — Use caution DXM inhibits serotonin reuptake at higher doses. Cases of serotonin toxicity with DXM + serotonergic agents exist. Particularly relevant in winter cold/flu season when Canadians commonly use DXM cough suppressants. Avoid OTC cough syrups containing DXM while using 5-HTP. Check labels — DXM is in many common Canadian cold products.
Alcohol Moderate Alcohol acutely increases serotonin release then depletes serotonin over time. Combined with 5-HTP's serotonin-boosting effect: short-term additive CNS effects (drowsiness, impaired coordination); longer-term, alcohol may blunt 5-HTP's sleep benefit by disrupting serotonin metabolism. Do not take 5-HTP within 4–6 hours of alcohol consumption.

Special populations

  • Pregnancy and breastfeeding: Serotonin is critical for fetal development. 5-HTP should not be used during pregnancy or lactation without medical supervision. Insufficient safety data; theoretical risk of fetal serotonin dysregulation.
  • EMS / eosinophilia-myalgia syndrome history: A 1989 outbreak of a serious condition (EMS) was linked to contaminated L-tryptophan supplements. While 5-HTP itself was not responsible, individuals with EMS history or eosinophilia of unknown cause should avoid 5-HTP as a precaution. Modern 5-HTP from reputable NPN-verified sources does not carry this risk, but caution remains appropriate.
  • Liver disease: 5-HTP is metabolised hepatically. People with impaired liver function may have altered 5-HTP clearance and increased risk of accumulation. Avoid in significant hepatic impairment without physician guidance.
  • Children and adolescents: No established safety or efficacy data for sleep use. Not recommended.
  • Down syndrome: People with Down syndrome have altered serotonin metabolism. 5-HTP has been studied in this population (at high doses, for different indications) with mixed results and significant adverse effects. Not appropriate for use without specialist supervision.

Buying 5-HTP in Canada (NPN guide)

5-HTP is regulated as a natural health product (NHP) in Canada. Any product sold with a therapeutic claim must carry a Health Canada NPN. The source material — Griffonia simplicifolia seed extract — and the extraction quality determine product reliability.

①8-digit NPN on label. All legitimate Canadian 5-HTP products require an NPN (e.g., NPN 80XXXXXXX). Verify at health-products.canada.ca. Products without an NPN have not been reviewed by Health Canada for quality, safety, or efficacy claims.
②Source: Griffonia simplicifolia seed extract. This is the standard and most studied source of 5-HTP. The label must state this. 5-HTP can theoretically be produced synthetically, but all reputable supplement-grade products use Griffonia extraction. If the source is not stated, ask the manufacturer or choose another product.
③5-HTP percentage stated. Better products state the percentage of 5-HTP in the Griffonia extract — commonly 98% 5-HTP from Griffonia seed. This is the level used in clinical trials. Lower purity extracts provide less 5-HTP per milligram of product.
④Dose per capsule: 50–100 mg. Most Canadian products sell 5-HTP at 50 mg or 100 mg per capsule. Start with 100 mg (one capsule). Avoid combination products that blend 5-HTP with other serotonergic herbs (St. John's Wort, SAMe) — the interaction risk increases.
⑤No St. John's Wort in the formula. Some "mood and sleep" combination products blend 5-HTP with St. John's Wort — this is a serotonin syndrome risk. Read the full ingredient list before buying any combination product.
⑥Third-party testing or COA available. Reputable Canadian brands (Natural Factors, AOR, Sisu) provide batch-level Certificates of Analysis confirming 5-HTP content matches label claim. This matters because Griffonia 5-HTP content varies by harvest and extraction.
⑦Price check: CA$15–25 for 60 × 100 mg capsules. A 2-month supply at 100 mg/night should cost $15–25 CAD from a reputable retailer. Significantly higher prices suggest unnecessary branding or formulations. Shoppers Drug Mart, Well.ca, and Amazon.ca all carry NPN-verified options.

Recommended Canadian brands

  • Natural Factors 5-HTP 100 mg — Griffonia simplicifolia 98%, NPN-verified, widely available at Well.ca and Amazon.ca. COA available on request. One of the most consistently formulated options in the Canadian market.
  • Sisu 5-HTP 100 mg — Canadian brand, NPN-verified, Griffonia source stated. Available at Shoppers Drug Mart and natural health retailers.
  • AOR 5-HTP — Higher-end Canadian brand with third-party testing documentation; more expensive but reliable quality. Available at Well.ca and AOR's direct website.
  • Jamieson — Does not currently carry a standalone 5-HTP at the time of writing; their combination sleep products should be checked carefully for St. John's Wort before purchase.

When 5-HTP won't fix your sleep

5-HTP is narrowly useful. It works along one pathway — serotonin support — and is irrelevant or counterproductive for many common sleep problems.

  • Obstructive sleep apnea: 5-HTP will not open a partially obstructed airway. Serotonin does modulate upper airway muscle tone, and there has been some research interest in this, but OTC 5-HTP doses are not clinically validated for apnea treatment. If you suspect sleep apnea (snoring, gasping, unrefreshed sleep), get a sleep study first.
  • Circadian rhythm disorders: Delayed sleep phase or jet lag is a timing problem. 5-HTP supports serotonin → melatonin conversion, but it does not reset the circadian clock. Melatonin at the correct time, combined with morning light therapy, is the appropriate intervention. See our melatonin guide.
  • Primary insomnia without anxiety or mood component: If you have never had anxiety or depression and your sleep difficulty appeared without a clear stress trigger, the serotonin pathway may not be the bottleneck. CBT-I addresses the conditioned hyperarousal that drives primary insomnia — 5-HTP does not. See our CBT-I guide.
  • Depression not responding to serotonin precursors: Some forms of depression are driven by dopamine, norepinephrine, or inflammatory dysregulation, not serotonin deficit. If you have tried 5-HTP for 4+ weeks and your mood and sleep have not improved, serotonin may not be the driver. See a physician — not more supplements.
  • Restless leg syndrome: RLS is dopamine-related. 5-HTP's serotonin boost is irrelevant and, in some individuals, serotonin elevation can actually worsen RLS by inhibiting dopaminergic tone. Do not use 5-HTP for RLS.
  • Pain-disrupted sleep: 5-HTP has some research in fibromyalgia (which involves both serotonin and pain), but for typical pain-disrupted sleep (arthritis, back pain, headaches), pain management is the appropriate intervention.

Frequently asked questions

Does 5-HTP help with sleep?

5-HTP can improve sleep quality and reduce sleep latency by increasing serotonin, which the brain converts to melatonin at night. Evidence is strongest for anxiety- or mood-linked sleep difficulty. It is not a sedative and does not work for sleep apnea, circadian disorders, or primary insomnia in healthy people. Allow 1–2 weeks of nightly use at 100 mg before evaluating. Do not use if you take SSRIs, SNRIs, MAOIs, tramadol, triptans, or St. John's Wort.

How long does 5-HTP take to work for sleep?

Typically 1–2 weeks of consistent nightly use. 5-HTP works by gradually increasing serotonin availability, which drives nocturnal melatonin production — an accumulative process, not an acute drug effect. Some people notice mild drowsiness on night one; most notice consistent sleep improvement after 7–14 days. Do not increase the dose within the first 2 weeks unless you have no side effects and no improvement at 100 mg.

What is the correct 5-HTP dosage for sleep in Canada?

Start with 100 mg taken with a light snack 30–45 minutes before bed in a dim-light environment. After 2 weeks with no side effects and partial improvement, you may increase to 200 mg. Do not exceed 300 mg/day for sleep — GI side effects increase substantially above this level, and serotonin-related adverse effects become more likely. Always buy Griffonia simplicifolia-sourced 5-HTP with a Health Canada NPN.

Can I take 5-HTP with melatonin?

Yes, with caution. 5-HTP supports endogenous melatonin production; exogenous melatonin adds to that. The combination is not dangerous in healthy people not taking serotonergic medications, but for most people 5-HTP alone (which naturally raises melatonin via the serotonin pathway) is sufficient. If combining, use 0.5 mg melatonin only — not the 5–10 mg doses common in Canadian pharmacies. Never combine 5-HTP + melatonin + any serotonergic drug.

Is 5-HTP safe to take in Canada?

5-HTP is an NHP regulated by Health Canada (requires NPN). It is safe in healthy adults not taking serotonergic medications, at doses under 300 mg/day. The critical safety issue is serotonin syndrome — do not take 5-HTP with SSRIs, SNRIs, MAOIs, tramadol, triptans, or St. John's Wort. Nausea is the most common side effect and is reduced by taking with food. Avoid during pregnancy. Buy Griffonia simplicifolia extract (98% 5-HTP) with NPN from Natural Factors, Sisu, or AOR.

Bottom line

5-HTP for sleep in Canada is a well-mechanised, moderately evidenced option for a specific profile: people whose sleep difficulty is upstream of a serotonin deficit — anxiety, low mood, chronic stress, or fibromyalgia. It works by increasing serotonin, which the brain converts to melatonin in darkness. Start at 100 mg nightly with a light snack, 30–45 minutes before bed in dim light, and allow 2 weeks before evaluating. The drug interaction picture is the most important thing to understand: if you take any SSRI, SNRI, MAOI, tramadol, triptan, or St. John's Wort, do not take 5-HTP without explicit physician guidance — serotonin syndrome is a genuine risk. For people not on serotonergic medications, 5-HTP is reasonably safe, inexpensive, and available from reputable NPN-verified Canadian brands at $15–25 CAD per 2 months.

Related reading

Not sure what's disrupting your sleep?

Take our free 7-question sleep assessment to identify your pattern and get a personalised starting point.

Take the Free Sleep Assessment